June 28 (Reuters) - Some U.S. stocks on the move on Friday:
U.S. stocks opened modestly lower as weakness in technology shares outweighed gains in other shares spurred by relief a premature pullback of central bank stimulus measures was unlikely. The Dow Jones industrial average was down 0.45 percent, the Standard & Poor’s 500 Index down 0.27 percent, and the Nasdaq Composite Index down 0.34 percent.
** BLACKBERRY, $10.72, down 25 pct (0930 ET)
Blackberry offered few signs of a long-promised turnaround on Friday, with an unexpected quarterly operating loss, few details on sales of its make-or-break new devices and no return to profit in the current quarter.
** AMEDISYS INC, $9.60, down 27.7 pct (0931 ET)
** GENTIVA HEALTHCARE SERVICES INC, $9.29, down 19 pct
** LHC GROUP INC, $19.76, 12 pct
** ALMOST FAMILY INC, $17.66, down 11.7 pct
** KINDRED HEALTHCARE INC, $12.81, down 2 pct
Reimbursement to home healthcare providers from the U.S. Medicare program will be cut by about 1.5 percent next year, under a rate change proposal made public by the Centers for Medicare and Medicaid Services on Thursday.
** EMMIS COMMUNICATIONS CORP, $2.25, up 24 pct (0937 ET)
The radio broadcaster reported a first-quarter profit, compared with a loss a year earlier. The company also reported higher quarterly revenue.
** ARCH COAL INC, $3.58, up 7 pct (0932 ET)
The coal producer said it would sell its Utah subsidiary Canyon Fuel Company for $435 million to Bowie Resources LLC as it looks to focus on metallurgical coal and optimize its thermal coal assets. Arch Coal said it expects to save capital and administrative cost of more than $200 million from 2014 through 2017.
** DENDREON CORP, $4.41, up 8 pct (0933 ET)
** RAPTOR PHARMACEUTICALS INC, $9.50, up 1.3 pct
** HOSPIRA, $36.56, up 1 pct
** ONYX PHARMACEUTICALS INC, $86.07, up 1 pct
Experts at the European Medicines Agency recommended approval of a host of drugs including Dendreon’s cancer vaccine Provenge, Raptor’s Procysbi that treats a rare genetic disorder called nephropathic cystinosis, Hospira’s Inflectra that treats rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis, and Stivarga, the colorectal cancer drug of Bayer and Onyx.
** BIOGEN IDEC INC, $220.15, up 5.4 pct (0936 ET)
French drugmaker Sanofi’s hopes in the multiple sclerosis market received a double boost on Friday as the European regulator backed an injectable treatment and adopted a more positive stance toward a pill for the neurodegenerative disease. The decisions lifted the stock of Biogen Idec, a leader in the U.S. multiple sclerosis space with its key drug Tysabri.
** AMERICAN SUPERCONDUCTOR CORP, $2.63, up 12.6 pct (0934 ET)
Chinese wind turbine maker Sinovel Wind Group Co and two of its employees were charged with stealing trade secrets from U.S.-based AMSC by the Department of Justice (DoJ) on Thursday.
** MOLYCORP INC, $5.91, up 5.3 pct (0935 ET)
The rare earths producer said the U.S. Securities and Exchange Commission has completed an investigation against the company and has not recommended any enforcement action. The SEC had started investigating the accuracy of Molycorp’s public disclosures last August.
** PACIFIC SUNWEAR OF CALIFORNIA, $3.70, up 11 pct (0947 ET)
Wedbush Securities Inc upgraded the surfwear maker’s stock to “outperform” from “neutral”, citing signs of improving sales of surf and skate clothing, expansion into women’s apparel with the opening of 200 new Brandy Melville stores and increasing margins due to less discounting. The brokerage also raised its price target on the stock to $4 from $3.75.
** SUNTECH POWER HOLDINGS CO LTD, $1.02, down 2 pct (0935 ET)
China-based solar panel maker, whose main unit is in insolvency proceedings, said it had struck a deal with a majority of its bondholders to defer payment on a $541 million loan until Aug. 30, the third time the company has reached such an agreement.
** ACCENTURE PLC, $70.09, down 12 pct (1000 ET)
** IBM CORP, $189.44, down 3 pct (1000 ET)
Outsourcing and consulting services provider Accenture cut its full-year outlook, citing a pullback in spending by its consulting business clients, after reporting third-quarter revenue below analysts’ estimates.
** CALAMP CORP, $14.64, up 2 pct (0936 ET)
The wireless device maker reported first-quarter results that beat Wall Street estimates as revenue rose in its high-margin business that provides technologies, products and services to wireless networks. The company also forecast second-quarter revenue largely above expectations. Canaccord Genuity raised its price target on the stock to $20 from $16.
** PFIZER INC, $28.52, up 1.2 pct (0938 ET)
The drugmaker authorized a $10 billion share repurchase program, in addition to the $3.9 billion remaining under its current share repurchase program.
** NIKE INC, $61.34, down 1.6 pct (0938 ET)
The sports goods maker, which posted a higher quarterly profit on Thursday, said orders for its clothes and shoes jumped, particularly in North America, but orders were flat in China, stripping out the effect of currency fluctuations. The company, which receives about 11 percent of its sales and 22 percent of its profit from China, said it expects revenue from the region to fall in the first half of 2014.
** DANA HOLDING CORP, $19.24, up 5.6 pct (0938 ET)
The auto parts supplier said it expanded its share repurchase program to up to $1 billion from $250 million.
** SHAW COMMUNICATIONS INC, $23.48, up 3 pct (0952 ET)
The dominant cable company in Western Canada reported a small rise in third-quarter profit, driven by higher cable rates, and the company raised its 2013 cash-flow forecast. (Compiled by Kanika Sikka; Editing by Don Sebastian)